KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC-Response

被引：0
|
作者：
Smits, Kim M. [1 ]
Paranjape, Trupti [3 ]
Nallur, Sunitha [3 ]
Wouters, Kim A. D. [1 ]
Weijenberg, Matty P. [2 ]
Schouten, Leo J. [2 ]
van den Brandt, Piet A. [2 ]
Bosman, Fred T. [1 ]
Weidhaas, Joanne B. [3 ]
van Engeland, Manon [1 ]
机构：
[1] Maastricht Univ, Ctr Med, GROW Sch Oncol & Dev Biol, Dept Pathol, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Ctr Med, GROW Sch Oncol & Dev Biol, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[3] Yale Univ, Dept Therapeut Radiol, New Haven, CT USA
来源：
CLINICAL CANCER RESEARCH | 2012年 / 18卷 / 12期
关键词：
LET-7; MICRORNA-BINDING; COLORECTAL-CANCER; 3'-UNTRANSLATED REGION;
D O I：
10.1158/1078-0432.CCR-12-1023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3489 / 3489
页数：1
相关论文
共 50 条
  • [1] KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC-Letter
    Ryan, Brid M.
    Robles, Ana I.
    Harris, Curtis C.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3487 - 3488
  • [2] TRPV6 is a prognostic marker in early-stage cervical squamous cell carcinoma
    Sun, Fei
    Xiao, Lu
    Jang, Xin-Xing
    Xiong, Ying
    Li, Qi
    Yue, Xiao-jing
    Wei, Yun-Jian
    Wei, Yan-Xing
    Ma, Yan-Lin
    Yu, Yan-Hong
    TUMOR BIOLOGY, 2016, 37 (12) : 15743 - 15751
  • [3] KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma
    Kadota, Kyuichi
    Sima, Camelia S.
    Arcila, Maria E.
    Hedvat, Cyrus
    Kris, Mark G.
    Jones, David R.
    Adusumilli, Prasad S.
    Travis, William D.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1579 - 1590
  • [4] Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
    Khadse, Anand
    Haakensen, Vilde D.
    Silwal-Pandit, Laxmi
    Hamfjord, Julian
    Micke, Patrick
    Botling, Johan
    Brustugun, Odd Terje
    Lingjaerde, Ole Christian
    Helland, Aslaug
    Kure, Elin H.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Tumour volume as a prognostic marker in early-stage nasopharyngeal carcinoma
    Poh, S.
    Mueller, S.
    Lam, W.
    Teo, P.
    Tan, H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S625 - S625
  • [6] Survivin immunoexpression: An independent prognostic marker of recurrence in early-stage breast cancer
    Belchior, Heloisa O. M.
    Andrade, Victor P.
    Lima, Marcos V. A.
    Cunha, Maria do P. S. S.
    Lemos, Monique B. C.
    Silva, Paulo G. B.
    Silva-Fernandes, Isabelle J. L.
    CANCER RESEARCH, 2021, 81 (04)
  • [7] Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix
    Eggen, Tormod
    Sager, Georg
    Arnes, Marit
    Pettersen, Inger
    Orbo, Anne
    ANTICANCER RESEARCH, 2011, 31 (06) : 2319 - 2325
  • [8] Loss of the epithelial marker CDX1 predicts poor prognosis in early-stage CRC patients
    Sole, Laura
    Lobo-Jarne, Teresa
    Cabre-Romans, Julia-Jie
    Gonzalez, Anton
    Fernandez, Lierni
    Marruecos, Laura
    Guix, Marta
    Cuatrecasas, Miriam
    Lopez, Sandra
    Bellosillo, Beatriz
    Torres, Ferran
    Iglesias, Mar
    Bigas, Anna
    Espinosa, Lluis
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2024, 1871 (03):
  • [9] CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
    Zhang, Yanwei
    Sun, Beibei
    Hu, Minjuan
    Lou, Yuqing
    Lu, Jun
    Zhang, Xueyan
    Wang, Huimin
    Qian, Jialin
    Chu, Tianqing
    Han, Baohui
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
    Smits, Kim M.
    Paranjape, Trupti
    Nallur, Sunitha
    Wouters, Kim A. D.
    Weijenberg, Matty P.
    Schouten, Leo J.
    van den Brandt, Piet A.
    Bosman, Fred T.
    Weidhaas, Joanne B.
    van Engeland, Manon
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7723 - 7731
12345